Guidance Clarifies EU Position On Alternatives To Notified Body On-Site Audits

Virtual notified body audits of medtech manufacturers are already taking place through necessity. Now there is guidance concerning if, when, where and how these audits should be carried out.

Audit

A new guidance on notified body audits during COVID-19 quarantine has been issued by the European Commission’s Medical Device Coordination Group (MDCG) to formally outline when alternatives to on-site audits, such as virtual audits, can take place for devices assessed in the context of the EU’s medical device directives.

Additionally, a task force has been set up under the MDCG Notified Body Oversight (NBO) working group tasked with the development of guidance to define the operational implementation details of...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Compliance

More from Policy & Regulation